1.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)
Lau, G, Yu, ML, Wong
More...
Lau, G, Yu, ML, Wong, GC, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, JM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tanwandee, T, Sarin, SK, Omata, M
Less
HEPATOLOGY INTERNATIONAL[1936-0533],
Published 2022,
Volume 16,
Issue 2,
Pages 486-487
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 1
2022影響因子:
6.6
发表年影響因子:
6.6
2.Achieving WHO target of HCV control in Hong Kong: challenges and strategies
Wang, YD, Cheng, G,
More...
Wang, YD, Cheng, G, Lau, G
Less
GLOBAL HEALTH & MEDICINE[2434-9186],
Published 2021,
Volume 3,
Issue 5,
Pages 276-282
收錄情况：
WOS
WOS核心合集引用: 0
2022影響因子:
2.6
3.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy
Lau, G, Yu, ML, Wong
More...
Lau, G, Yu, ML, Wong, G, Thompson, A, Ghazinian, H, Hou, JL, Piratvisuth, T, Jia, JD, Mizokami, M, Cheng, G, Chen, GF, Liu, ZW, Baatarkhuu, O, Cheng, AL, Ng, WL, Lau, P, Mok, T, Chang, EM, Hamid, S, Dokmeci, AK, Gani, RA, Payawal, DA, Chow, P, Park, JW, Strasser, SI, Mohamed, R, Win, KM, Tawesak, T, Sarin, SK, Omata, M
Less
HEPATOLOGY INTERNATIONAL[1936-0533],
Published 2021,
Volume 15,
Issue 5,
Pages 1031-1048
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 52
2022影響因子:
6.6
发表年影響因子:
9.046
4.Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"
Ji, D, Cheng, G, Lau
More...
Ji, D, Cheng, G, Lau, G
Less
JOURNAL OF HEPATOLOGY[0168-8278],
Published 2021,
Volume 74,
Issue 2,
Pages 484-485
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 8
2022影響因子:
25.7
发表年影響因子:
30.083
5.Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19
Ji, D, Zhang, MJ, Qi
More...
Ji, D, Zhang, MJ, Qin, EQ, Zhang, LQ, Xu, J, Wang, YD, Cheng, G, Wang, F, Lau, G
Less
METABOLISM-CLINICAL AND EXPERIMENTAL[0026-0495],
Published 2021,
Volume 115,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 17
2022影響因子:
9.8
发表年影響因子:
13.934
6.The CALL Score for Predicting Outcomes in Patients With COVID-19 Reply
Ji, D, Qin, EQ, Zhan
More...
Ji, D, Qin, EQ, Zhang, DW, Cheng, G, Lau, G
Less
CLINICAL INFECTIOUS DISEASES[1058-4838],
Published 2021,
Volume 72,
Issue 1,
Pages 183-183
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 0
2022影響因子:
11.8
发表年影響因子:
20.999
7.The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19) Reply
Ji, D, Qin, EQ, Zhan
More...
Ji, D, Qin, EQ, Zhang, DW, Cheng, G, Lau, G
Less
CLINICAL INFECTIOUS DISEASES[1058-4838],
Published 2021,
Volume 73,
Issue 9,
Pages E2819-E2819
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 0
2022影響因子:
11.8
发表年影響因子:
20.999
8.Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study
DongJi, Guo-feng Che
More...
DongJi, Guo-feng Chen, Xiao-xia Niu, Mingjie Zhang, Cheng Wang, Qing Shao, Vanessa Wu, Yudong Wang, Gregory Cheng, Selwyn J. Hurwitz, Raymond F. Schinazi, George Lau
Less
Metabolism Open[2589-9368],
Published 2021,
Volume 10,
9.Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening
Shao, FY, Lyu, XY, M
More...
Shao, FY, Lyu, XY, Miao, K, Xie, LS, Wang, HT, Xiao, H, Li, J, Chen, Q, Ding, RB, Chen, P, Xing, FQ, Zhang, X, Luo, GH, Zhu, WL, Cheng, G, Lon, NW, Martin, SE, Wang, GY, Chen, GK, Dai, YL, Deng, CX
Less
ADVANCED SCIENCE[2198-3844],
Published 2020,
Volume 7,
Issue 23,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 11
2022影響因子:
15.1
发表年影響因子:
16.806
10.Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia
Zhang, LQ, Zhang, MJ
More...
Zhang, LQ, Zhang, MJ, Du, X, Cheng, YF, Cheng, G
Less
BRITISH JOURNAL OF HAEMATOLOGY[0007-1048],
Published 2020,
Volume 189,
Issue 2,
Pages 369-378
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 30
2022影響因子:
6.5
发表年影響因子:
6.998
11.Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Ji, D, Qin, EQ, Xu,
More...
Ji, D, Qin, EQ, Xu, J, Zhang, DW, Cheng, G, Wang, YD, Lau, G
Less
JOURNAL OF HEPATOLOGY[0168-8278],
Published 2020,
Volume 73,
Issue 2,
Pages 451-453
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 369
2022影響因子:
25.7
发表年影響因子:
25.083
12.Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'
Ji, D, Xu, J, Qin, E
More...
Ji, D, Xu, J, Qin, EQ, Zhang, DW, Cheng, G, Wang, YD, Lau, G
Less
JOURNAL OF HEPATOLOGY[0168-8278],
Published 2020,
Volume 73,
Issue 3,
Pages 718-719
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 6
2022影響因子:
25.7
发表年影響因子:
25.083
13.Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation
Liu, HL, He, X, Wang
More...
Liu, HL, He, X, Wang, YD, Zhou, SN, Zhang, DL, Zhu, JY, He, Q, Zhu, ZJ, Li, GM, Sun, LB, Wang, JL, Cheng, G, Liu, ZW, Lau, G
Less
HEPATOLOGY INTERNATIONAL[1936-0533],
Published 2020,
Volume 14,
Issue 4,
Pages 432-436
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 46
2022影響因子:
6.6
发表年影響因子:
6.047
14.Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score
Ji, D, Zhang, DW, Xu
More...
Ji, D, Zhang, DW, Xu, J, Chen, Z, Yang, TN, Zhao, P, Chen, GF, Cheng, G, Wang, YD, Bi, JF, Tan, L, Lau, G, Qin, EQ
Less
CLINICAL INFECTIOUS DISEASES[1058-4838],
Published 2020,
Volume 71,
Issue 6,
Pages 1393-1399
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 395
2022影響因子:
11.8
发表年影響因子:
9.079
15.Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
Lau, G, Sharma, M
More...
Lau, G, Sharma, M
Less
HEPATOLOGY INTERNATIONAL[1936-0533],
Published 2020,
Volume 14,
Issue 4,
Pages 415-428
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 50
2022影響因子:
6.6
发表年影響因子:
6.047
16.Effect of COVID-19 on patients with compensated chronic liver diseases
Ji, D, Zhang, DW, Ya
More...
Ji, D, Zhang, DW, Yang, TN, Mu, JS, Zhao, P, Xu, J, Li, C, Cheng, G, Wang, YD, Chen, Z, Qin, EQ, Lau, G
Less
HEPATOLOGY INTERNATIONAL[1936-0533],
Published 2020,
Volume 14,
Issue 5,
Pages 701-710
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 48
2022影響因子:
6.6
发表年影響因子:
6.047
18.Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns
Lam, PL, Lee, KKH, W
More...
Lam, PL, Lee, KKH, Wong, RSM, Cheng, GYM, Bian, ZX, Chui, CH, Gambari, R
Less
CRITICAL REVIEWS IN MICROBIOLOGY[1040-841X],
Published 2018,
Volume 44,
Issue 1,
Pages 40-78
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 40
2022影響因子:
6.5
发表年影響因子:
5.697
19.Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)
Zhang, LQ, Zhang, MJ
More...
Zhang, LQ, Zhang, MJ, Du, X, Cheng, YF, Cheng, G
Less
BLOOD[0006-4971],
Published 2018,
Volume 132,
收錄情况：
WOS
WOS核心合集引用: 1
2022影響因子:
20.3
发表年影響因子:
16.601
20.Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China
Yee, A, Tsui, NBY, C
More...
Yee, A, Tsui, NBY, Chang, YN, Au, CSM, Fok, M, Lau, LT, Chung, T, Cheng, G, Kwan, RYC, Leung, AYM, Lau, JYN, Dai, DLK
Less
HONG KONG MEDICAL JOURNAL[1024-2708],
Published 2018,
Volume 24,
Issue 5,
Pages 492-500
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 16
2022影響因子:
2.7
发表年影響因子:
1.588
